Other Species / Isoforms
  Hck (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S27-p
PRMGCVKsRFLRDGs
0 1
Hck (human) PRMGCMKSkFLQVGG S27
Hck iso2 (human) __MGCMKSKFLQVGG S6
Hck iso3 (human) __MGCMKSKFLQVGG S6
Hck iso4 (human) PRMGCMKSKFLQVGG S27
Hck (mouse) PRMGCVKsRFLRDGs S27-p
Hck (rat) PRMGCVKSRFLREGS S27
R28
RMGCVKsRFLRDGsK
0 1
Hck (human) RMGCMKSkFLQVGGN K28-ub
Hck iso2 (human) _MGCMKSKFLQVGGN K7
Hck iso3 (human) _MGCMKSKFLQVGGN K7
Hck iso4 (human) RMGCMKSKFLQVGGN K28
Hck (mouse) RMGCVKsRFLRDGsK R28
Hck (rat) RMGCVKSRFLREGSK R28
S34-p
sRFLRDGsKASKTEP
Upstream
0 4
Treatment
  • ischemia
Hck (human) SkFLQVGGNtFSKTE G34
Hck iso2 (human) SKFLQVGGNTFSKTE G13
Hck iso3 (human) SKFLQVGGNTFSKTE G13
Hck iso4 (human) SKFLQVGGNTFSKTE G34
Hck (mouse) sRFLRDGsKASKTEP S34-p
Hck (rat) SRFLREGSKASKIEP S34
A36
FLRDGsKASKTEPSA
0 4
Hck (human) FLQVGGNtFSKTETS T36-p
Hck iso2 (human) FLQVGGNTFSKTETS T15
Hck iso3 (human) FLQVGGNTFSKTETS T15
Hck iso4 (human) FLQVGGNTFSKTETS T36
Hck (mouse) FLRDGsKASKTEPSA A36
Hck (rat) FLREGSKASKIEPNA A36
Y50-p
ANQKGPVyVPDPTSS
Upstream
Downstream
1 75
Effects on Modified Protein
  • enzymatic activity, induced
Kinase, in vitro:
  • Hck (mouse)
Putative in vivo kinases:
  • Hck (mouse)
Treatment
  • IL-33
Hck (human) ASPHCPVyVPDPTST Y51-p
Hck iso2 (human) ASPHCPVYVPDPTST Y30
Hck iso3 (human) ASPHCPVYVPDPTST Y30
Hck iso4 (human) ASPHCPVYVPDPTST Y51
Hck (mouse) ANQKGPVyVPDPTSS Y50-p
Hck (rat) ANQKGPVYVPDPTSP Y50
Y85-p
DTIVVALyDYEAIHR
0 1
Hck (human) DIIVVALYDyEAIHH Y87
Hck iso2 (human) DIIVVALYDYEAIHH Y66
Hck iso3 (human) DIIVVALYDYEAIHH Y65
Hck iso4 (human) DIIVVALYDYEAIHH Y86
Hck (mouse) DTIVVALyDYEAIHR Y85-p
Hck (rat) DTIVVALYDYEAIHR Y85
Y87
IVVALyDYEAIHRED
0 2
Hck (human) IVVALYDyEAIHHED Y89-p
Hck iso2 (human) IVVALYDYEAIHHED Y68
Hck iso3 (human) IVVALYDYEAIHHED Y67
Hck iso4 (human) IVVALYDYEAIHHED Y88
Hck (mouse) IVVALyDYEAIHRED Y87
Hck (rat) IVVALYDYEAIHRED Y87
A109
QMVVLEEAGEWWKAR
0 1
Hck (human) QMVVLEEsGEWWKAR S111-p
Hck iso2 (human) QMVVLEESGEWWKAR S90
Hck iso3 (human) QMVVLEESGEWWKAR S89
Hck iso4 (human) QMVVLEESGEWWKAR S110
Hck (mouse) QMVVLEEAGEWWKAR A109
Hck (rat) QMVVLEESGEWWKAR S109
K122
ARSLATKKEGyIPSN
0 1
Hck (human) ARSLATRkEGyIPSN K124-ub
Hck iso2 (human) ARSLATRKEGYIPSN K103
Hck iso3 (human) ARSLATRKEGYIPSN K102
Hck iso4 (human) ARSLATRKEGYIPSN K123
Hck (mouse) ARSLATKKEGyIPSN K122
Hck (rat) ARSLATKKEGYIPSN K122
Y125-p
LATKKEGyIPSNYVA
0 2
Hck (human) LATRkEGyIPSNYVA Y127-p
Hck iso2 (human) LATRKEGYIPSNYVA Y106
Hck iso3 (human) LATRKEGYIPSNYVA Y105
Hck iso4 (human) LATRKEGYIPSNYVA Y126
Hck (mouse) LATKKEGyIPSNYVA Y125-p
Hck (rat) LATKKEGYIPSNYVA Y125
Y178
SETTKGSYSLSVRDF
0 1
Hck (human) SETTKGSysLSVRDY Y180-p
Hck iso2 (human) SETTKGSYSLSVRDY Y159
Hck iso3 (human) SETTKGSYSLSVRDY Y158
Hck iso4 (human) SETTKGSYSLSVRDY Y179
Hck (mouse) SETTKGSYSLSVRDF Y178
Hck (rat) SETTKGSYSLSVRDF Y178
S179
ETTKGSYSLSVRDFD
0 1
Hck (human) ETTKGSysLSVRDYD S181-p
Hck iso2 (human) ETTKGSYSLSVRDYD S160
Hck iso3 (human) ETTKGSYSLSVRDYD S159
Hck iso4 (human) ETTKGSYSLSVRDYD S180
Hck (mouse) ETTKGSYSLSVRDFD S179
Hck (rat) ETTKGSYSLSVRDFD S179
T200-p
VKHYKIRtLDSGGFy
0 4
Hck (human) VKHYKIRtLDNGGFy T202-p
Hck iso2 (human) VKHYKIRTLDNGGFY T181
Hck iso3 (human) VKHYKIRTLDNGGFY T180
Hck iso4 (human) VKHYKIRTLDNGGFY T201
Hck (mouse) VKHYKIRtLDSGGFy T200-p
Hck (rat) VKHYKIRTLDSGGFy T200
Y207-p
tLDSGGFyISPRSTF
Upstream
1 430
Treatment
  • IFN-gamma
Hck (human) tLDNGGFyISPRSTF Y209-p
Hck iso2 (human) TLDNGGFYISPRSTF Y188
Hck iso3 (human) TLDNGGFYISPRSTF Y187
Hck iso4 (human) TLDNGGFYISPRSTF Y208
Hck (mouse) tLDSGGFyISPRSTF Y207-p
Hck (rat) TLDSGGFyISPRSTF Y207-p
K226
ELVLHYKKGKDGLCQ
0 1
Hck (human) ELVDHYKkGNDGLCQ K228-ac
Hck iso2 (human) ELVDHYKKGNDGLCQ K207
Hck iso3 (human) ELVDHYKKGNDGLCQ K206
Hck iso4 (human) ELVDHYKKGNDGLCQ K227
Hck (mouse) ELVLHYKKGKDGLCQ K226
Hck (rat) ELVVHYKKGKDGLCQ K226
S236
DGLCQKLSVPCVSPK
0 1
Hck (human) DGLCQKLsVPCMSSK S238-p
Hck iso2 (human) DGLCQKLSVPCMSSK S217
Hck iso3 (human) DGLCQKLSVPCMSSK S216
Hck iso4 (human) DGLCQKLSVPCMSSK S237
Hck (mouse) DGLCQKLSVPCVSPK S236
Hck (rat) DGLCQKLSVPCVSPK S236
S259
AWEIPRESLQMEKKL
0 1
Hck (human) AWEIPREsLKLEKKL S261-p
Hck iso2 (human) AWEIPRESLKLEKKL S240
Hck iso3 (human) AWEIPRESLKLEKKL S239
Hck iso4 (human) AWEIPRESLKLEKKL S260
Hck (mouse) AWEIPRESLQMEKKL S259
Hck (rat) AWEIPRESLQMEKKL S259
K281
VWMATYNKHTKVAVK
0 1
Hck (human) VWMATYNkHTkVAVK K283-ub
Hck iso2 (human) VWMATYNKHTKVAVK K262
Hck iso3 (human) VWMATYNKHTKVAVK K261
Hck iso4 (human) VWMATYNKHTKVAVK K282
Hck (mouse) VWMATYNKHTKVAVK K281
Hck (rat) VWMATYNKHTKVAVK K281
K284
ATYNKHTKVAVKTMK
0 1
Hck (human) ATYNkHTkVAVKTMK K286-ub
Hck iso2 (human) ATYNKHTKVAVKTMK K265
Hck iso3 (human) ATYNKHTKVAVKTMK K264
Hck iso4 (human) ATYNKHTKVAVKTMK K285
Hck (mouse) ATYNKHTKVAVKTMK K284
Hck (rat) ATYNKHTKVAVKTMK K284
S309
AEANLMKSLQHDKLV
0 1
Hck (human) AEANVMKtLQHDKLV T311-p
Hck iso2 (human) AEANVMKTLQHDKLV T290
Hck iso3 (human) AEANVMKTLQHDKLV T289
Hck iso4 (human) AEANVMKTLQHDKLV T310
Hck (mouse) AEANLMKSLQHDKLV S309
Hck (rat) AEANLMKTLQHDKLV T309
F328
VVSQEPIFIVTEFMA
0 8
Hck (human) VVTKEPIyIITEFMA Y330-p
Hck iso2 (human) VVTKEPIYIITEFMA Y309
Hck iso3 (human) VVTKEPIYIITEFMA Y308
Hck iso4 (human) VVTKEPIYIITEFMA Y329
Hck (mouse) VVSQEPIFIVTEFMA F328
Hck (rat) VVSQEPIFIVTEFMA F328
Y409-p
RIIEDNEytAREGAK
Upstream
Downstream
8 2156
Hck (human)
Y411-p
Hck iso2 (human)
Y390-p
Hck iso3 (human)
Y389-p
Hck iso4 (human)
Y410-p
Hck (mouse)
Y409-p
Hck (rat)
Y409-p
Effects on Modified Protein
  • enzymatic activity, induced
  • phosphorylation
Kinase, in vitro:
  • Hck (mouse)
Putative in vivo kinases:
  • Hck (mouse)
Regulatory protein:
  • Src iso1 (mouse)
Treatment
  • lysophosphatidylcholine
Hck (human) RVIEDNEytAREGAK Y411-p
Hck iso2 (human) RVIEDNEYTAREGAK Y390
Hck iso3 (human) RVIEDNEYTAREGAK Y389
Hck iso4 (human) RVIEDNEYTAREGAK Y410
Hck (mouse) RIIEDNEytAREGAK Y409-p
Hck (rat) RIIEDNEytAREGAK Y409-p
T410-p
IIEDNEytAREGAKF
0 17
Hck (human) VIEDNEytAREGAKF T412-p
Hck iso2 (human) VIEDNEYTAREGAKF T391
Hck iso3 (human) VIEDNEYTAREGAKF T390
Hck iso4 (human) VIEDNEYTAREGAKF T411
Hck (mouse) IIEDNEytAREGAKF T410-p
Hck (rat) IIEDNEytAREGAKF T410-p
S440
TIKSDVWSFGILLME
0 1
Hck (human) TIKSDVWsFGILLME S442-p
Hck iso2 (human) TIKSDVWSFGILLME S421
Hck iso3 (human) TIKSDVWSFGILLME S420
Hck iso4 (human) TIKSDVWSFGILLME S441
Hck (mouse) TIKSDVWSFGILLME S440
Hck (rat) TIKSDVWSFGILLME S440
S460
RIPYPGMSNPEVIRA
0 1
Hck (human) RIPYPGMsNPEVIRA S462-p
Hck iso2 (human) RIPYPGMSNPEVIRA S441
Hck iso3 (human) RIPYPGMSNPEVIRA S440
Hck iso4 (human) RIPYPGMSNPEVIRA S461
Hck (mouse) RIPYPGMSNPEVIRA S460
Hck (rat) RIPYPGMSNPEVIRA S460
Y513-p
QSVLDDFyTATESQy
0 1
Hck (human) QSVLDDFYTATEsQy Y515
Hck iso2 (human) QSVLDDFYTATESQY Y494
Hck iso3 (human) QSVLDDFYTATESQY Y493
Hck iso4 (human) QSVLDDFYTATESQY Y514
Hck (mouse) QSVLDDFyTATESQy Y513-p
Hck (rat) QSVLDDFYTATESQY Y513
S518
DFyTATESQyQQQP_
0 7
Hck (human) DFYTATEsQyQQQP_ S520-p
Hck iso2 (human) DFYTATESQYQQQP_ S499
Hck iso3 (human) DFYTATESQYQQQP_ S498
Hck iso4 (human) DFYTATESQYQQQP_ S519
Hck (mouse) DFyTATESQyQQQP_ S518
Hck (rat) DFYTATESQYQQQP_ S518
Y520-p
yTATESQyQQQP___
Upstream
Downstream
3 333
Effects on Modified Protein
  • enzymatic activity, inhibited
Treatment
  • IFN-gamma
Hck (human) YTATEsQyQQQP___ Y522-p
Hck iso2 (human) YTATESQYQQQP___ Y501
Hck iso3 (human) YTATESQYQQQP___ Y500
Hck iso4 (human) YTATESQYQQQP___ Y521
Hck (mouse) yTATESQyQQQP___ Y520-p
Hck (rat) YTATESQYQQQP___ Y520